img

Global Gut Microbiome Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gut Microbiome Market Insights, Forecast to 2034

The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.
Market Analysis and InsightsGlobal Gut Microbiome Market
Global Gut Microbiome market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gut Microbiome industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Gut Microbiome key companies include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. Viome, Carbiotix, Ixcela, Inc are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Gut Microbiome were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Gut Microbiome market and estimated to attract more attentions from industry insiders and investors.
Gut Microbiome can be divided into Obesity, Inflammatory Bowel Disease (IBD), Diabetes and Others, etc. Obesity is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Gut Microbiome is widely used in various fields, such as Human and Animal, etc. Human provides greatest supports to the Gut Microbiome industry development. In 2022, global % revenue of Gut Microbiome went into Human filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Gut Microbiome market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Gut Microbiome market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others

Segment by Application


Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gut Microbiome introduction, etc. Gut Microbiome Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Gut Microbiome
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gut Microbiome Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Obesity
1.2.3 Inflammatory Bowel Disease (IBD)
1.2.4 Diabetes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gut Microbiome Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Human
1.3.3 Animal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gut Microbiome Market Perspective (2018-2033)
2.2 Global Gut Microbiome Growth Trends by Region
2.2.1 Gut Microbiome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gut Microbiome Historic Market Size by Region (2018-2023)
2.2.3 Gut Microbiome Forecasted Market Size by Region (2024-2033)
2.3 Gut Microbiome Market Dynamics
2.3.1 Gut Microbiome Industry Trends
2.3.2 Gut Microbiome Market Drivers
2.3.3 Gut Microbiome Market Challenges
2.3.4 Gut Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gut Microbiome by Players
3.1.1 Global Gut Microbiome Revenue by Players (2018-2023)
3.1.2 Global Gut Microbiome Revenue Market Share by Players (2018-2023)
3.2 Global Gut Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gut Microbiome, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gut Microbiome Market Concentration Ratio
3.4.1 Global Gut Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gut Microbiome Revenue in 2022
3.5 Global Key Players of Gut Microbiome Head office and Area Served
3.6 Global Key Players of Gut Microbiome, Product and Application
3.7 Global Key Players of Gut Microbiome, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gut Microbiome Breakdown Data by Type
4.1 Global Gut Microbiome Historic Market Size by Type (2018-2023)
4.2 Global Gut Microbiome Forecasted Market Size by Type (2024-2033)
5 Gut Microbiome Breakdown Data by Application
5.1 Global Gut Microbiome Historic Market Size by Application (2018-2023)
5.2 Global Gut Microbiome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gut Microbiome Market Size (2018-2033)
6.2 North America Gut Microbiome Market Size by Type
6.2.1 North America Gut Microbiome Market Size by Type (2018-2023)
6.2.2 North America Gut Microbiome Market Size by Type (2024-2033)
6.2.3 North America Gut Microbiome Market Share by Type (2018-2033)
6.3 North America Gut Microbiome Market Size by Application
6.3.1 North America Gut Microbiome Market Size by Application (2018-2023)
6.3.2 North America Gut Microbiome Market Size by Application (2024-2033)
6.3.3 North America Gut Microbiome Market Share by Application (2018-2033)
6.4 North America Gut Microbiome Market Size by Country
6.4.1 North America Gut Microbiome Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Gut Microbiome Market Size by Country (2018-2023)
6.4.3 North America Gut Microbiome Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gut Microbiome Market Size (2018-2033)
7.2 Europe Gut Microbiome Market Size by Type
7.2.1 Europe Gut Microbiome Market Size by Type (2018-2023)
7.2.2 Europe Gut Microbiome Market Size by Type (2024-2033)
7.2.3 Europe Gut Microbiome Market Share by Type (2018-2033)
7.3 Europe Gut Microbiome Market Size by Application
7.3.1 Europe Gut Microbiome Market Size by Application (2018-2023)
7.3.2 Europe Gut Microbiome Market Size by Application (2024-2033)
7.3.3 Europe Gut Microbiome Market Share by Application (2018-2033)
7.4 Europe Gut Microbiome Market Size by Country
7.4.1 Europe Gut Microbiome Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Gut Microbiome Market Size by Country (2018-2023)
7.4.3 Europe Gut Microbiome Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gut Microbiome Market Size (2018-2033)
8.2 China Gut Microbiome Market Size by Type
8.2.1 China Gut Microbiome Market Size by Type (2018-2023)
8.2.2 China Gut Microbiome Market Size by Type (2024-2033)
8.2.3 China Gut Microbiome Market Share by Type (2018-2033)
8.3 China Gut Microbiome Market Size by Application
8.3.1 China Gut Microbiome Market Size by Application (2018-2023)
8.3.2 China Gut Microbiome Market Size by Application (2024-2033)
8.3.3 China Gut Microbiome Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Gut Microbiome Market Size (2018-2033)
9.2 Asia Gut Microbiome Market Size by Type
9.2.1 Asia Gut Microbiome Market Size by Type (2018-2023)
9.2.2 Asia Gut Microbiome Market Size by Type (2024-2033)
9.2.3 Asia Gut Microbiome Market Share by Type (2018-2033)
9.3 Asia Gut Microbiome Market Size by Application
9.3.1 Asia Gut Microbiome Market Size by Application (2018-2023)
9.3.2 Asia Gut Microbiome Market Size by Application (2024-2033)
9.3.3 Asia Gut Microbiome Market Share by Application (2018-2033)
9.4 Asia Gut Microbiome Market Size by Region
9.4.1 Asia Gut Microbiome Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Gut Microbiome Market Size by Region (2018-2023)
9.4.3 Asia Gut Microbiome Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gut Microbiome Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Gut Microbiome Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gut Microbiome Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gut Microbiome Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Gut Microbiome Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Gut Microbiome Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gut Microbiome Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gut Microbiome Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Gut Microbiome Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Gut Microbiome Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gut Microbiome Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Gut Microbiome Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gut Microbiome Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Viome
11.1.1 Viome Company Details
11.1.2 Viome Business Overview
11.1.3 Viome Gut Microbiome Introduction
11.1.4 Viome Revenue in Gut Microbiome Business (2018-2023)
11.1.5 Viome Recent Developments
11.2 Carbiotix
11.2.1 Carbiotix Company Details
11.2.2 Carbiotix Business Overview
11.2.3 Carbiotix Gut Microbiome Introduction
11.2.4 Carbiotix Revenue in Gut Microbiome Business (2018-2023)
11.2.5 Carbiotix Recent Developments
11.3 Ixcela, Inc
11.3.1 Ixcela, Inc Company Details
11.3.2 Ixcela, Inc Business Overview
11.3.3 Ixcela, Inc Gut Microbiome Introduction
11.3.4 Ixcela, Inc Revenue in Gut Microbiome Business (2018-2023)
11.3.5 Ixcela, Inc Recent Developments
11.4 Novome Biotechnologies
11.4.1 Novome Biotechnologies Company Details
11.4.2 Novome Biotechnologies Business Overview
11.4.3 Novome Biotechnologies Gut Microbiome Introduction
11.4.4 Novome Biotechnologies Revenue in Gut Microbiome Business (2018-2023)
11.4.5 Novome Biotechnologies Recent Developments
11.5 Kintai Therapeutics
11.5.1 Kintai Therapeutics Company Details
11.5.2 Kintai Therapeutics Business Overview
11.5.3 Kintai Therapeutics Gut Microbiome Introduction
11.5.4 Kintai Therapeutics Revenue in Gut Microbiome Business (2018-2023)
11.5.5 Kintai Therapeutics Recent Developments
11.6 ProDigest
11.6.1 ProDigest Company Details
11.6.2 ProDigest Business Overview
11.6.3 ProDigest Gut Microbiome Introduction
11.6.4 ProDigest Revenue in Gut Microbiome Business (2018-2023)
11.6.5 ProDigest Recent Developments
11.7 Caelus Health
11.7.1 Caelus Health Company Details
11.7.2 Caelus Health Business Overview
11.7.3 Caelus Health Gut Microbiome Introduction
11.7.4 Caelus Health Revenue in Gut Microbiome Business (2018-2023)
11.7.5 Caelus Health Recent Developments
11.8 LNC Therapeutics
11.8.1 LNC Therapeutics Company Details
11.8.2 LNC Therapeutics Business Overview
11.8.3 LNC Therapeutics Gut Microbiome Introduction
11.8.4 LNC Therapeutics Revenue in Gut Microbiome Business (2018-2023)
11.8.5 LNC Therapeutics Recent Developments
11.9 AnimalBiome
11.9.1 AnimalBiome Company Details
11.9.2 AnimalBiome Business Overview
11.9.3 AnimalBiome Gut Microbiome Introduction
11.9.4 AnimalBiome Revenue in Gut Microbiome Business (2018-2023)
11.9.5 AnimalBiome Recent Developments
11.10 Assembly Biosciences
11.10.1 Assembly Biosciences Company Details
11.10.2 Assembly Biosciences Business Overview
11.10.3 Assembly Biosciences Gut Microbiome Introduction
11.10.4 Assembly Biosciences Revenue in Gut Microbiome Business (2018-2023)
11.10.5 Assembly Biosciences Recent Developments
11.11 Enterome BioScience
11.11.1 Enterome BioScience Company Details
11.11.2 Enterome BioScience Business Overview
11.11.3 Enterome BioScience Gut Microbiome Introduction
11.11.4 Enterome BioScience Revenue in Gut Microbiome Business (2018-2023)
11.11.5 Enterome BioScience Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gut Microbiome Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Obesity
Table 3. Key Players of Inflammatory Bowel Disease (IBD)
Table 4. Key Players of Diabetes
Table 5. Key Players of Others
Table 6. Global Gut Microbiome Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Gut Microbiome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Gut Microbiome Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Gut Microbiome Market Share by Region (2018-2023)
Table 10. Global Gut Microbiome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Gut Microbiome Market Share by Region (2024-2033)
Table 12. Gut Microbiome Market Trends
Table 13. Gut Microbiome Market Drivers
Table 14. Gut Microbiome Market Challenges
Table 15. Gut Microbiome Market Restraints
Table 16. Global Gut Microbiome Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Gut Microbiome Revenue Share by Players (2018-2023)
Table 18. Global Top Gut Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiome as of 2022)
Table 19. Global Gut Microbiome Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Gut Microbiome Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Gut Microbiome, Headquarters and Area Served
Table 22. Global Key Players of Gut Microbiome, Product and Application
Table 23. Global Key Players of Gut Microbiome, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Gut Microbiome Revenue Market Share by Type (2018-2023)
Table 27. Global Gut Microbiome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Gut Microbiome Revenue Market Share by Type (2024-2033)
Table 29. Global Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Gut Microbiome Revenue Share by Application (2018-2023)
Table 31. Global Gut Microbiome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Gut Microbiome Revenue Share by Application (2024-2033)
Table 33. North America Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Gut Microbiome Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Gut Microbiome Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Gut Microbiome Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Gut Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Gut Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Gut Microbiome Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Gut Microbiome Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Gut Microbiome Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Gut Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Gut Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Gut Microbiome Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Gut Microbiome Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Gut Microbiome Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Gut Microbiome Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Gut Microbiome Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Gut Microbiome Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Gut Microbiome Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gut Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gut Microbiome Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gut Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gut Microbiome Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gut Microbiome Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Gut Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Gut Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 65. Viome Company Details
Table 66. Viome Business Overview
Table 67. Viome Gut Microbiome Product
Table 68. Viome Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 69. Viome Recent Developments
Table 70. Carbiotix Company Details
Table 71. Carbiotix Business Overview
Table 72. Carbiotix Gut Microbiome Product
Table 73. Carbiotix Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 74. Carbiotix Recent Developments
Table 75. Ixcela, Inc Company Details
Table 76. Ixcela, Inc Business Overview
Table 77. Ixcela, Inc Gut Microbiome Product
Table 78. Ixcela, Inc Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 79. Ixcela, Inc Recent Developments
Table 80. Novome Biotechnologies Company Details
Table 81. Novome Biotechnologies Business Overview
Table 82. Novome Biotechnologies Gut Microbiome Product
Table 83. Novome Biotechnologies Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 84. Novome Biotechnologies Recent Developments
Table 85. Kintai Therapeutics Company Details
Table 86. Kintai Therapeutics Business Overview
Table 87. Kintai Therapeutics Gut Microbiome Product
Table 88. Kintai Therapeutics Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 89. Kintai Therapeutics Recent Developments
Table 90. ProDigest Company Details
Table 91. ProDigest Business Overview
Table 92. ProDigest Gut Microbiome Product
Table 93. ProDigest Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 94. ProDigest Recent Developments
Table 95. Caelus Health Company Details
Table 96. Caelus Health Business Overview
Table 97. Caelus Health Gut Microbiome Product
Table 98. Caelus Health Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 99. Caelus Health Recent Developments
Table 100. LNC Therapeutics Company Details
Table 101. LNC Therapeutics Business Overview
Table 102. LNC Therapeutics Gut Microbiome Product
Table 103. LNC Therapeutics Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 104. LNC Therapeutics Recent Developments
Table 105. AnimalBiome Company Details
Table 106. AnimalBiome Business Overview
Table 107. AnimalBiome Gut Microbiome Product
Table 108. AnimalBiome Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 109. AnimalBiome Recent Developments
Table 110. Assembly Biosciences Company Details
Table 111. Assembly Biosciences Business Overview
Table 112. Assembly Biosciences Gut Microbiome Product
Table 113. Assembly Biosciences Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 114. Assembly Biosciences Recent Developments
Table 115. Enterome BioScience Company Details
Table 116. Enterome BioScience Business Overview
Table 117. Enterome BioScience Gut Microbiome Product
Table 118. Enterome BioScience Revenue in Gut Microbiome Business (2018-2023) & (US$ Million)
Table 119. Enterome BioScience Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gut Microbiome Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Gut Microbiome Market Share by Type: 2022 VS 2033
Figure 3. Obesity Features
Figure 4. Inflammatory Bowel Disease (IBD) Features
Figure 5. Diabetes Features
Figure 6. Others Features
Figure 7. Global Gut Microbiome Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Gut Microbiome Market Share by Application: 2022 VS 2033
Figure 9. Human Case Studies
Figure 10. Animal Case Studies
Figure 11. Gut Microbiome Report Years Considered
Figure 12. Global Gut Microbiome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Gut Microbiome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Gut Microbiome Market Share by Region: 2022 VS 2033
Figure 15. Global Gut Microbiome Market Share by Players in 2022
Figure 16. Global Top Gut Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gut Microbiome as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gut Microbiome Revenue in 2022
Figure 18. North America Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Gut Microbiome Market Share by Type (2018-2033)
Figure 20. North America Gut Microbiome Market Share by Application (2018-2033)
Figure 21. North America Gut Microbiome Market Share by Country (2018-2033)
Figure 22. United States Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Gut Microbiome Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Gut Microbiome Market Share by Type (2018-2033)
Figure 26. Europe Gut Microbiome Market Share by Application (2018-2033)
Figure 27. Europe Gut Microbiome Market Share by Country (2018-2033)
Figure 28. Germany Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Gut Microbiome Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Gut Microbiome Market Share by Type (2018-2033)
Figure 36. China Gut Microbiome Market Share by Application (2018-2033)
Figure 37. Asia Gut Microbiome Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Gut Microbiome Market Share by Type (2018-2033)
Figure 39. Asia Gut Microbiome Market Share by Application (2018-2033)
Figure 40. Asia Gut Microbiome Market Share by Region (2018-2033)
Figure 41. Japan Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gut Microbiome Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gut Microbiome Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Gut Microbiome Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Gut Microbiome Market Share by Country (2018-2033)
Figure 51. Brazil Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Gut Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Viome Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 58. Carbiotix Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 59. Ixcela, Inc Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 60. Novome Biotechnologies Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 61. Kintai Therapeutics Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 62. ProDigest Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 63. Caelus Health Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 64. LNC Therapeutics Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 65. AnimalBiome Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 66. Assembly Biosciences Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 67. Enterome BioScience Revenue Growth Rate in Gut Microbiome Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed